Synthetic Genomics Raises $35M in Ongoing Funding Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics has raised $35 million in private equity financing through an ongoing funding round expected to reach $50 million, according to a filing with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.